Literature DB >> 24648874

Effect of preoperative flow rate on postoperative retention and voiding difficulty after transobturator tape operation.

Sungjune Kim1, Jungbum Bae1, Minchul Cho1, Kwangsoo Lee1, Haewon Lee1, Taeyong Jun1.   

Abstract

PURPOSE: Controversy exists over the preoperative risk factors for postoperative urinary retention after the midurethral sling procedure for stress urinary incontinence (SUI). We intended to analyze the effect of preoperative flow rate on postoperative urinary retention after the transobturator tape (TOT) operation.
MATERIALS AND METHODS: A total of 322 patients who underwent TOT from June 2006 to May 2012 were included in this retrospective study. All patients were preoperatively investigated for urinary symptoms and underwent preoperative urodynamic studies including urine flow rate. Postoperative urinary retention, voiding difficulty, and uroflowmetry were checked. Urinary retention was defined as the need for additional catheterization longer than 1 day. Patients were divided by preoperative peak flow rate (Qmax) of 15 mL/s (low Qmax group and normal Qmax group).
RESULTS: There were 3 cases of postoperative urinary retention (0.9%) and 52 cases of voiding difficulty (16.1%). The low Qmax group included 40 patients (12.4%) and the normal Qmax group included 282 patients (87.5%). Between the two groups, there were no significant differences in age, previous pelvic surgery history, or past medical history. The low Qmax group had higher scores for voided volume and detrusor pressure at Qmax. However, there was no significant difference in postoperative voiding difficulty between the two groups. Furthermore, three patients who experienced postoperative retention showed high flow rates preoperatively.
CONCLUSIONS: Our results suggest that voiding difficulty in the group with low preoperative flow was tolerable and the treatment success rate was comparable to that in patients in the normal flow group. According to our analysis, patients with a low flow rate preoperatively can be safely treated with TOT for SUI.

Entities:  

Keywords:  Transobturator tape; Urinary stress incontinence; Voiding dysfunction

Year:  2014        PMID: 24648874      PMCID: PMC3956948          DOI: 10.4111/kju.2014.55.3.190

Source DB:  PubMed          Journal:  Korean J Urol        ISSN: 2005-6737


  28 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

Review 2.  Comparison of tension-free vaginal tape and transobturator tape procedure for the treatment of stress urinary incontinence.

Authors:  Cheng-Yu Long; Chun-Shuo Hsu; Ming-Ping Wu; Cheng-Min Liu; Tsu-Nai Wang; Eing-Mei Tsai
Journal:  Curr Opin Obstet Gynecol       Date:  2009-08       Impact factor: 1.927

3.  Complications of midurethral slings and their management.

Authors:  Victor W Nitti
Journal:  Can Urol Assoc J       Date:  2012-10       Impact factor: 1.862

4.  Short-term complications of pubovaginal sling procedure for genuine stress incontinence in women.

Authors:  P T Chan; C Fournier; J Corcos
Journal:  Urology       Date:  2000-02       Impact factor: 2.649

5.  Tension-free vaginal tape for the treatment of urodynamic stress incontinence with intrinsic sphincteric deficiency.

Authors:  Fabio Ghezzi; Maurizio Serati; Antonella Cromi; Stefano Uccella; Stefano Salvatore; Paola Triacca; Pierfrancesco Bolis
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-10-07

6.  Long-term results of the tension-free vaginal tape (TVT) procedure for surgical treatment of female stress urinary incontinence.

Authors:  C G Nilsson; N Kuuva; C Falconer; M Rezapour; U Ulmsten
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2001

7.  Suburethral tape via the obturator route: is the TOT a simplification of the TVT?

Authors:  G Mellier; B Benayed; S Bretones; J C Pasquier
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004 Jul-Aug

8.  Identification of risk factors for voiding dysfunction following TVT placement.

Authors:  Ambroise Salin; Sophie Conquy; Caroline Elie; Cyril Touboul; Jérome Parra; Marc Zerbib; Bernard Debré; Delphine Amsellem-Ouazana
Journal:  Eur Urol       Date:  2006-11-03       Impact factor: 20.096

9.  Factors predictive of post-TVT voiding dysfunction.

Authors:  Tim Dawson; Vanessa Lawton; Elisabeth Adams; David Richmond
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-03-09

10.  A Comparison of the Clinical Efficacy of the Transobturator Adjustable Tape (TOA) and Transobturator Tape (TOT) for Treating Female Stress Urinary Incontinence with Intrinsic Sphincter Deficiency: Short-term Results.

Authors:  Tae Hoon Oh; Ju Hyun Shin; Yong Gil Na
Journal:  Korean J Urol       Date:  2012-02-20
View more
  4 in total

1.  High urinary flow in women with stress incontinence: corrected flow-age nomogram evaluation after a transobturator tape procedure.

Authors:  Yasuhide Kitagawa; Kazutaka Narimoto; Satoko Urata; Shohei Kawaguchi; Masato Kuribayashi; Mikio Namiki
Journal:  Int Urogynecol J       Date:  2016-01-25       Impact factor: 2.894

2.  Analysis of voiding dysfunction after transobturator tape procedure for stress urinary incontinence.

Authors:  Chang Ahn; Jungbum Bae; Kwang Soo Lee; Hae Won Lee
Journal:  Korean J Urol       Date:  2015-12-10

3.  A study of transobturator tape in stress urinary incontinence.

Authors:  Rahul Vishwanath Mayekar; Archana Anilkumar Bhosale; Khushboo Vikram Kandhari; Yogeshwar Sadashiv Nandanwar; Sadaf Sadique Shaikh
Journal:  Urol Ann       Date:  2017 Jan-Mar

4.  Efficacy of urodynamic studies in predicting long-term outcomes of the transobturator tape: do they augment clinical assessment?

Authors:  Stefanie M Croghan; Grainne Costigan; Niall O'Dwyer; Eoin MacCraith; Gerry Lennon
Journal:  Cent European J Urol       Date:  2019-09-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.